Day High: Day Low: Volume: Jan 21, 2022 10:56 PM EST Data Provided by Refinitiv. Minimum 15 minutes delayed. Press Releases December 14, 2021 Centessa Pharmaceuticals Initiates Global Phase 3 ACTION Study of Lixivaptan in Autosomal Dominant Polycystic Kidney Disease, Reports Initial Positive Safety Data from ALERT Study, and Announces Notice of Allowance for Key Lixivaptan U.S. Patent Application December 13, 2021 Centessa Pharmaceuticals Announces Addition to NASDAQ Biotechnology Index Site - View All - News View all press releases Events & Presentations December 2, 2021 9:15 AM EST 4th Annual Evercore ISI HealthCONx Conference Listen to Webcast November 18, 2021 8:00 AM GMT Jefferies London Healthcare Conference Listen to Webcast Site - View All - Events View all events & presentations
